Left ventricular thrombosis after anterior myocardial infarction with and without thrombolytic treatment
- 1 June 1995
- journal article
- clinical trial
- Published by Wiley in Journal of Internal Medicine
- Vol. 237 (6) , 563-569
- https://doi.org/10.1111/j.1365-2796.1995.tb00886.x
Abstract
To examine the incidence of left ventricular thrombus in patients with anterior myocardial infarction, with and without streptokinase treatment. To identify predictors of thrombus development. Consecutive patients prospectively studied during the hospitalized period. Echocardiography was performed within 3 days of admission and before discharge. Umeå University Hospital, a teaching hospital in Northern Sweden. Ninety-nine patients with anterior myocardial infarction of whom 74 were treated with streptokinase. Left ventricular thrombus and left ventricular segmental myocardial function. During the hospital stay, a thrombus developed in 46% (95% confidence interval [CI], 35-57%) of the patients in the thrombolysis group and in 40% (95% CI, 21-59%) of the patients in the non-thrombolysis group. No difference in left ventricular segmental myocardial function was found between the thrombolysis and non-thrombolysis groups at hospital discharge. No embolic events were observed. The occurrence of a left ventricular thrombus at hospital discharge was significantly associated with previous myocardial infarction, peak enzyme levels, left ventricular global and segmental dysfunction and an increased dose of peroral diuretics or use of parenteral diuretics. In a multiple logistic regression model, left ventricular segmental dysfunction was the most important predictor of left ventricular thrombus. Thrombolytic treatment with streptokinase does not prevent the development of a left ventricular thrombus but the risk of embolic complications is low. The left ventricular segmental myocardial score can be used to assess the risk of thrombus development, also, after thrombolysis.Keywords
This publication has 26 references indexed in Scilit:
- Effects of intravenous recombinant tissue-type plasminogen activator therapy on the incidence and associations of left ventricular thrombus in patients with a first acute Q wave anterior myocardial infarctionAmerican Heart Journal, 1991
- Incidence of left ventricular thrombi formation after thrombolytic therapy with recombinant tissue plasminogen activator, heparin, and aspirin in patients with acute myocardial infarctionAmerican Heart Journal, 1991
- Influence of thrombolytic treatment followed by full dose anticoagulation on the frequency of left ventricular thrombi in acute myocardial infarctionThe American Journal of Cardiology, 1989
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- Reduced incidence of left ventricular thrombi with intravenous streptokinase in acute anterior myocardial infarction: prospective evaluation by cross-sectional echocardiographyInternational Journal of Cardiology, 1988
- Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarctionThe American Journal of Cardiology, 1987
- Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction: a two-dimensional echocardiographic study.Circulation, 1985
- Effect of early systemic thrombolytic therapy on left ventricular mural thrombus formation in acute anterior myocardial infarctionThe American Journal of Cardiology, 1984
- Incidence of Left-Ventricular Thrombosis after Acute Transmural Myocardial InfarctionNew England Journal of Medicine, 1981
- Observations on detecting left ventricular thrombus with two dimensional echocardiography: emphasis on avoidance of false positive diagnosesThe American Journal of Cardiology, 1981